Analyst Sentiment on Outset Medical (OM) Remains Strong Following Q4 Results [Yahoo! Finance]
Outset Medical (NASDAQ:OM) had its price target lowered by analysts at BTIG Research from $17.00 to $15.00. They now have a "buy" rating on the stock.
Outset Medical, Inc. (OM) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Outset Medical outlines 5%–9% revenue growth for 2026 with next-gen Tablo launch and gross margin expansion [Seeking Alpha]
Outset Medical Q4 Earnings Call Highlights [Yahoo! Finance]